Stratagene to face PCR patent suit:
This article was originally published in Clinica
Executive Summary
Applera has filed suit against research and immunodiagnostic tools manufacturer Stratagene for alleged infringement of its '934 patent. The products involved in the dispute are instruments used to perform real-time PCR. La Jolla, California-based Stratagene is already licensed to manufacture, use and sell PCR thermal cyclers originally developed by Applied BioSystems, one of Applera's two main business groups.